12:00 AM
 | 
Apr 18, 2011
 |  BC Week In Review  |  Company News  |  Deals

J&J, Merck deal

Merck and Johnson & Johnson concluded a 2009 arbitration over a dispute related to a 1998 deal between J&J's Centocor Ortho Biotech Inc. subsidiary and Schering-Plough Corp. for autoimmune drugs Remicade infliximab and Simponi golimumab. Merck's...

Read the full 188 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >